Univercells is a technology company delivering novel biomanufacturing platforms, aiming at making biologics available & affordable to all.
The scale-X™ carbo bioreactor: flexible GMP viral production at bench scale in adherent or suspension processes
Producing viral products for vaccines or cell and gene therapy starts with cell culture, where bioprocessing equipment must be selected to ensure conditions established at bench-scale can be successfully translated to the clinics and onwards. ... Continued
The NevoLine™ Upstream platform provides intensified and automated large scale virus manufacturing in a compact footprint
This system combines the principles of process intensification and chaining to provide high performance, cost-effective GMP virus manufacturing. The platform delivers commercial scale upstream manufacturing within a 3 m² system, a 3-fold reduction in equipment footprint compared to conventional technologies. Moreover, the system is especially suited to fit in modular facilities often utilized for rapid and flexible implementation of manufacturing capacity....Continued
In this podcast and accompanying article, we interviewed Dr. Alex Chatel, Product Manager, Viral Applications, Univercells about the biggest challenges facing vaccine manufacturing today, why it is so difficult to manufacture and deliver vaccines to the developing world and how a novel technology with the support of the Gates Foundation is poised to address these challenges....Continued